Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) and LyondellBasell Industries (NYSE:LYB – Get Free Report) are both large-cap materials companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, risk and dividends.
Analyst Recommendations
This is a summary of recent recommendations and price targets for Novozymes A/S and LyondellBasell Industries, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Novozymes A/S | 0 | 1 | 0 | 2 | 3.33 |
| LyondellBasell Industries | 3 | 9 | 7 | 1 | 2.30 |
LyondellBasell Industries has a consensus target price of $72.78, suggesting a potential upside of 27.56%. Given LyondellBasell Industries’ higher possible upside, analysts plainly believe LyondellBasell Industries is more favorable than Novozymes A/S.
Profitability
This table compares Novozymes A/S and LyondellBasell Industries’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Novozymes A/S | 15.59% | 6.56% | 4.37% |
| LyondellBasell Industries | 4.06% | 21.94% | 6.73% |
Valuation and Earnings
This table compares Novozymes A/S and LyondellBasell Industries”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Novozymes A/S | $4.70 billion | 5.69 | $660.28 million | $1.69 | 38.21 |
| LyondellBasell Industries | $30.15 billion | 0.61 | -$738.00 million | $3.96 | 14.41 |
Novozymes A/S has higher earnings, but lower revenue than LyondellBasell Industries. LyondellBasell Industries is trading at a lower price-to-earnings ratio than Novozymes A/S, indicating that it is currently the more affordable of the two stocks.
Dividends
Novozymes A/S pays an annual dividend of $0.39 per share and has a dividend yield of 0.6%. LyondellBasell Industries pays an annual dividend of $2.76 per share and has a dividend yield of 4.8%. Novozymes A/S pays out 23.1% of its earnings in the form of a dividend. LyondellBasell Industries pays out 69.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. LyondellBasell Industries has increased its dividend for 14 consecutive years. LyondellBasell Industries is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Institutional & Insider Ownership
0.0% of Novozymes A/S shares are owned by institutional investors. Comparatively, 71.2% of LyondellBasell Industries shares are owned by institutional investors. 0.1% of LyondellBasell Industries shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Volatility and Risk
Novozymes A/S has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500. Comparatively, LyondellBasell Industries has a beta of 0.29, suggesting that its share price is 71% less volatile than the S&P 500.
Summary
LyondellBasell Industries beats Novozymes A/S on 10 of the 18 factors compared between the two stocks.
About Novozymes A/S
Novozymes A/S was a Denmark-based biotechnology company that developed and produced enzymes and microorganisms for industrial and consumer applications. Its solutions were used in areas including household care, food and beverages, agriculture, animal health and bioenergy. The company’s products included enzymes used in detergents, baking, brewing and biofuel production, as well as microbial solutions for agricultural and other industrial processes. Novozymes served customers in markets around the world.
About LyondellBasell Industries
LyondellBasell Industries (NYSE: LYB) is a global chemicals and plastics company that makes materials and products used by manufacturers in a range of industries. Its businesses span the production of olefins, such as ethylene and propylene, and polyolefins, including polyethylene and polypropylene. The company also produces intermediates and derivatives, develops advanced polymer compounds, and provides chemical-process technology and related services. Its products are used in applications including packaging, transportation, construction, consumer goods and healthcare.
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
